Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

Lignende værker

• The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.
  af: Blackburn, M. J., et al.
  Udgivet: (1984)
• Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow.
  af: Ferrero, D, et al.
  Udgivet: (1983)
• The effect of etoposide on human CFU-GM.
  af: Bailey-Wood, R., et al.
  Udgivet: (1985)
• Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to Interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)
  af: Zeidner, Joshua F, et al.
  Udgivet: (2014)
• Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
  af: Sukhai, Mahadeo A., et al.
  Udgivet: (2012)